CLTC and breast carcinoma: The estrogen pathway has been proved to be a classic pathway to maintain the proliferation of breast cancer cells. CLTC (Figure 5E) and PSMD12 (Figure 5F) were significantly correlated with G2M checkpoint and E2F target channels.